Literature DB >> 26648033

Regulatory single nucleotide polymorphisms at the beginning of intron 2 of the human KRAS gene.

Elena V Antontseva1, Marina Yu Matveeva, Natalia P Bondar, Elena V Kashina, Elena Yu Leberfarb, Leonid O Bryzgalov, Polina A Gervas, Anastasia A Ponomareva, Nadezhda V Cherdyntseva, Yury L Orlov, Tatiana I Merkulova.   

Abstract

There are two regulatory single nucleotide polymorphisms (rSNPs) at the beginning of the second intron of the mouse K-ras gene that are strongly associated with lung cancer susceptibility. We performed functional analysis of three SNPs (rs12228277: T greater than A, rs12226937: G greater than A, and rs61761074: T greater than G) located in the same region of human KRAS. We found that rs12228277 and rs61761074 result in differential binding patterns of lung nuclear proteins to oligonucleotide probes corresponding two alternative alleles; in both cases, the transcription factor NF-Y is involved. G greater than A substitution (rs12226937) had no effect on the binding of lung nuclear proteins. However, all the nucleotide substitutions under study showed functional effects in a luciferase reporter assay. Among them, rs61761074 demonstrated a significant correlation with allele frequency in non-small-cell lung cancer (NSCLC). Taken together, the results of our study suggest that a T greater than G substitution at nucleotide position 615 in the second intron of the KRAS gene (rs61761074) may represent a promising genetic marker of NSCLC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26648033     DOI: 10.1007/s12038-015-9567-8

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  50 in total

Review 1.  rSNP_Guide: an integrated database-tools system for studying SNPs and site-directed mutations in transcription factor binding sites.

Authors:  Julia V Ponomarenko; Galina V Orlova; Tatyana I Merkulova; Elena V Gorshkova; Oleg N Fokin; Gennady V Vasiliev; Anatoly S Frolov; Mikhail P Ponomarenko
Journal:  Hum Mutat       Date:  2002-10       Impact factor: 4.878

2.  Long-range function of an intergenic retrotransposon.

Authors:  Wenhu Pi; Xingguo Zhu; Min Wu; Yongchao Wang; Sadanand Fulzele; Ali Eroglu; Jianhua Ling; Dorothy Tuan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

3.  The mechanism by which TATA-box polymorphisms associated with human hereditary diseases influence interactions with the TATA-binding protein.

Authors:  Irina Drachkova; Ludmila Savinkova; Tatyana Arshinova; Mikhail Ponomarenko; Sergey Peltek; Nikolay Kolchanov
Journal:  Hum Mutat       Date:  2014-03-31       Impact factor: 4.878

4.  Point mutations within 663-666 bp of intron 6 of the human TDO2 gene, associated with a number of psychiatric disorders, damage the YY-1 transcription factor binding site.

Authors:  G V Vasiliev; V M Merkulov; V F Kobzev; T I Merkulova; M P Ponomarenko; N A Kolchanov
Journal:  FEBS Lett       Date:  1999-11-26       Impact factor: 4.124

5.  KRAS alleles: the LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel.

Authors:  Samrat T Kundu; Sunitha Nallur; Trupti Paranjape; Marta Boeke; Joanne B Weidhaas; Frank J Slack
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

Review 6.  Hyperactive Ras in developmental disorders and cancer.

Authors:  Suzanne Schubbert; Kevin Shannon; Gideon Bollag
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

7.  The NF-Y complex negatively regulates Caenorhabditis elegans tbx-2 expression.

Authors:  Angenee C Milton; Adelaide V Packard; Lynn Clary; Peter G Okkema
Journal:  Dev Biol       Date:  2013-08-08       Impact factor: 3.582

8.  Beta-thalassemia due to a T----A mutation within the ATA box.

Authors:  Y J Fei; T A Stoming; G D Efremov; D G Efremov; R Battacharia; J M Gonzalez-Redondo; C Altay; A Gurgey; T H Huisman
Journal:  Biochem Biophys Res Commun       Date:  1988-06-16       Impact factor: 3.575

9.  NF-Y coassociates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors.

Authors:  Joseph D Fleming; Giulio Pavesi; Paolo Benatti; Carol Imbriano; Roberto Mantovani; Kevin Struhl
Journal:  Genome Res       Date:  2013-04-17       Impact factor: 9.043

10.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

View more
  3 in total

1.  Regulatory single nucleotide polymorphisms (rSNPs) at the promoters 1A and 1B of the human APC gene.

Authors:  Marina Yu Matveeva; Elena V Kashina; Vasily V Reshetnikov; Leonid O Bryzgalov; Elena V Antontseva; Natalia P Bondar; Tatiana I Merkulova
Journal:  BMC Genet       Date:  2016-12-22       Impact factor: 2.797

2.  Mutation Enrichment and Transcriptomic Activation Signatures of 419 Molecular Pathways in Cancer.

Authors:  Marianna A Zolotovskaia; Victor S Tkachev; Alexander P Seryakov; Denis V Kuzmin; Dmitry E Kamashev; Maxim I Sorokin; Sergey A Roumiantsev; Anton A Buzdin
Journal:  Cancers (Basel)       Date:  2020-01-22       Impact factor: 6.639

Review 3.  Proteasome regulators in pancreatic cancer.

Authors:  Nirosha J Murugan; Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2022-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.